AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
COMPLETE REMISSION AFTER TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ARSENIC TRIOXIDE
Authors: SOIGNET SL MASLAK P WANG ZG JHANWAR S CALLEJA E DARDASHTI LJ CORSO D DEBLASIO A GABRILOVE J SCHEINBERG DA PANDOLFI PP WARRELL RP
Citation: Sl. Soignet et al., COMPLETE REMISSION AFTER TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ARSENIC TRIOXIDE, The New England journal of medicine, 339(19), 1998, pp. 1341-1348
OVEREXPRESSION OF BASIC FIBROBLAST-GROWTH-FACTOR IN MCF-7 HUMAN BREAST-CANCER CELLS - LACK OF CORRELATION BETWEEN INHIBITION OF CELL-GROWTHAND MAP KINASE ACTIVATION
Authors: WIEDER R FENIG E WANG HS WANG Q PAGLIN S MENZEL T GABRILOVE J FUKS Z YAHALOM J
Citation: R. Wieder et al., OVEREXPRESSION OF BASIC FIBROBLAST-GROWTH-FACTOR IN MCF-7 HUMAN BREAST-CANCER CELLS - LACK OF CORRELATION BETWEEN INHIBITION OF CELL-GROWTHAND MAP KINASE ACTIVATION, Journal of cellular physiology, 177(3), 1998, pp. 411-425
EFFECTS OF PRIOR THERAPY ON THE IN-VITRO PROLIFERATIVE POTENTIAL OF STEM-CELL FACTOR PLUS FILGRASTIM-MOBILIZED CD34-POSITIVE PROGENITOR CELLS
Authors: SHAPIRO F YAO TJ MOSKOWITZ C REICH L WUEST DL HEIMFELD S MCNIECE IK GABRILOVE J NIMER S MOORE MAS
Citation: F. Shapiro et al., EFFECTS OF PRIOR THERAPY ON THE IN-VITRO PROLIFERATIVE POTENTIAL OF STEM-CELL FACTOR PLUS FILGRASTIM-MOBILIZED CD34-POSITIVE PROGENITOR CELLS, Clinical cancer research, 3(9), 1997, pp. 1571-1578
ARSENIC TRIOXIDE INDUCES APOPTOSIS IN K562 CHRONIC MYELOGENOUS LEUKEMIA (ML) CELLS
Authors: CALLEJA E KONIG A WARRELL R GABRILOVE J
Citation: E. Calleja et al., ARSENIC TRIOXIDE INDUCES APOPTOSIS IN K562 CHRONIC MYELOGENOUS LEUKEMIA (ML) CELLS, Blood, 90(10), 1997, pp. 3636-3636
AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (APBPCT) USING INCREASED DOSE TOTAL-BODY IRRADIATION (TBI) AND HIGH-DOSE VP-16 AS CONDITIONING IN ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: MASLAK P YAHALOM J COADYLYONS N CHILDS B FRANK R GABRILOVE J MICHAELI J NIESVIZKY R PEARSE R REICH L WUEST D NIMER S
Citation: P. Maslak et al., AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (APBPCT) USING INCREASED DOSE TOTAL-BODY IRRADIATION (TBI) AND HIGH-DOSE VP-16 AS CONDITIONING IN ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML), Blood, 90(10), 1997, pp. 4565-4565
USE OF STEM-CELL FACTOR (STEGMEN(R), SCF) AND FILGRASTIM (G-CSF) IN APLASTIC-ANEMIA (AA) PATIENTS (PTS) WHO HAVE FAILED ATG ALG THERAPY/
Authors: KURZROCK R PAQUETTE R GRATWOHL A DONEY K GABRILOVE J PATTERSON M RIVERA C WYRES M DAVIS MW YOUNG N
Citation: R. Kurzrock et al., USE OF STEM-CELL FACTOR (STEGMEN(R), SCF) AND FILGRASTIM (G-CSF) IN APLASTIC-ANEMIA (AA) PATIENTS (PTS) WHO HAVE FAILED ATG ALG THERAPY/, Blood, 90(10), 1997, pp. 762-762
MELARSOPROL, AN ORGANIC ARSENICAL, IN THE TREATMENT OF REFRACTORY LEUKEMIA - LABORATORY AND CLINICAL-RESULTS
Authors: SOIGNET SL RIVI R KONIG A TONG WP GABRILOVE J SCHEINBERG DA PANDOLFI PP WARRELL RP
Citation: Sl. Soignet et al., MELARSOPROL, AN ORGANIC ARSENICAL, IN THE TREATMENT OF REFRACTORY LEUKEMIA - LABORATORY AND CLINICAL-RESULTS, Blood, 90(10), 1997, pp. 2258-2258
RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR AND FILGRASTIM FOR PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION AND TRANSPLANTATION IN NON-HODGKINS-LYMPHOMA PATIENTS - RESULTS OF A PHASE I II TRIAL/
Authors: MOSKOWITZ CH STIFF P GORDON MS MCNIECE I HO AD COSTA JJ BROUN ER BAYER RA WYRES M HILL J JELACAMAXWELL K NICHOLS CR BROWN SL NIMER SD GABRILOVE J
Citation: Ch. Moskowitz et al., RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR AND FILGRASTIM FOR PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION AND TRANSPLANTATION IN NON-HODGKINS-LYMPHOMA PATIENTS - RESULTS OF A PHASE I II TRIAL/, Blood, 89(9), 1997, pp. 3136-3147
GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) - BIOLOGY AND CLINICAL STATUS
Authors: JAKUBOWSKI A GABRILOVE J
Citation: A. Jakubowski et J. Gabrilove, GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) - BIOLOGY AND CLINICAL STATUS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(1), 1996, pp. 5-20
FILGRASTIM (R-METHUG-CSF) - THE FIRST 10 YEARS
Authors: WELTE K GABRILOVE J BRONCHUD MH PLATZER E MORSTYN G
Citation: K. Welte et al., FILGRASTIM (R-METHUG-CSF) - THE FIRST 10 YEARS, Blood, 88(6), 1996, pp. 1907-1929
INITIAL CLINICAL-STUDY OF A NOVEL ORGANIC ARSENICAL, MELARSOPROL, IN PATIENTS WITH ADVANCED LEUKEMIA
Authors: SOIGNET S TONG WP GABRILOVE J SCHEINBERG DA PANDOLFI PP WARRELL RP
Citation: S. Soignet et al., INITIAL CLINICAL-STUDY OF A NOVEL ORGANIC ARSENICAL, MELARSOPROL, IN PATIENTS WITH ADVANCED LEUKEMIA, Blood, 88(10), 1996, pp. 865-865
ELEVATED INTRACELLULAR LEVEL OF BASIC FIBROBLAST GROWTH-FACTOR CORRELATES WITH STAGE OF CHRONIC LYMPHOCYTIC-LEUKEMIA AND IS ASSOCIATED WITHRESISTANCE TO FLUDARABINE
Authors: MENZEL T RAHMAN Z CALLEJA E WHITE K WILSON EL WIEDER R GABRILOVE J
Citation: T. Menzel et al., ELEVATED INTRACELLULAR LEVEL OF BASIC FIBROBLAST GROWTH-FACTOR CORRELATES WITH STAGE OF CHRONIC LYMPHOCYTIC-LEUKEMIA AND IS ASSOCIATED WITHRESISTANCE TO FLUDARABINE, Blood, 87(3), 1996, pp. 1056-1063
A PILOT-STUDY OF THE BIOLOGIC AND THERAPEUTIC EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
Authors: JAKUBOWSKI A GORDON M TAFURI A SCHUSTER S ANDREEFF M SHIEH JH VINCENT M GABRILOVE J
Citation: A. Jakubowski et al., A PILOT-STUDY OF THE BIOLOGIC AND THERAPEUTIC EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA, Leukemia, 9(11), 1995, pp. 1799-1804
TREATMENT OF CHRONIC NEUTROPENIA ASSOCIATED WITH LARGE GRANULAR LYMPHOCYTOSIS WITH CYCLOSPORINE-A AND FILGRASTIM
Authors: JAKUBOWSKI A WINTON EF GENCARELLI A GABRILOVE J
Citation: A. Jakubowski et al., TREATMENT OF CHRONIC NEUTROPENIA ASSOCIATED WITH LARGE GRANULAR LYMPHOCYTOSIS WITH CYCLOSPORINE-A AND FILGRASTIM, American journal of hematology, 50(4), 1995, pp. 288-291
THE PROLIFERATIVE POTENTIAL OF PERIPHERAL-BLOOD CD34(+) CELLS INVERSELY CORRELATES WITH PRIOR THERAPY
Authors: SHAPIRO F YAO TJ OUERIJERO M MOSKOWITZ C REICH L WUEST DL HEIMFELD S MCNIECE IK GABRILOVE J NIMER S MOORE MAS
Citation: F. Shapiro et al., THE PROLIFERATIVE POTENTIAL OF PERIPHERAL-BLOOD CD34(+) CELLS INVERSELY CORRELATES WITH PRIOR THERAPY, Blood, 86(10), 1995, pp. 472-472
BASIC FIBROBLAST GROWTH-FACTOR DELAYS DNA TOPOISOMERASE INHIBITOR-INDUCED APOPTOSIS IN K562 CHRONIC MYELOID-LEUKEMIA CELLS
Authors: CALLEJA E MENZEL T KONIG A WRAZEL L MASLAK P GABRILOVE J
Citation: E. Calleja et al., BASIC FIBROBLAST GROWTH-FACTOR DELAYS DNA TOPOISOMERASE INHIBITOR-INDUCED APOPTOSIS IN K562 CHRONIC MYELOID-LEUKEMIA CELLS, Blood, 86(10), 1995, pp. 2078-2078
BASIC FIBROBLAST GROWTH-FACTOR (BFGF) UP-REGULATES EXPRESSION OF BCL-2 IN CHRONIC LYMPHOID LEUKEMIA-CELL LINES RESULTING IN DELAYED APOPTOSIS
Authors: KONIG A MENZEL T CALLEJA E GENCARELLI A GABRILOVE J
Citation: A. Konig et al., BASIC FIBROBLAST GROWTH-FACTOR (BFGF) UP-REGULATES EXPRESSION OF BCL-2 IN CHRONIC LYMPHOID LEUKEMIA-CELL LINES RESULTING IN DELAYED APOPTOSIS, Blood, 86(10), 1995, pp. 3334-3334
BASIC FIBROBLAST GROWTH-FACTOR (BFGF) UP-REGULATES EXPRESSION OF P53 AND P21 IN 2 EBV-TRANSFORMED B-PROLYMPHOCYTIC LEUKEMIA-CELL LINES
Authors: MENZEL T KONIG A CALLEJA E GABRILOVE J
Citation: T. Menzel et al., BASIC FIBROBLAST GROWTH-FACTOR (BFGF) UP-REGULATES EXPRESSION OF P53 AND P21 IN 2 EBV-TRANSFORMED B-PROLYMPHOCYTIC LEUKEMIA-CELL LINES, Blood, 86(10), 1995, pp. 3343-3343
RELEASE OF GPI-ANCHORED MEMBRANE-PROTEINS BY A CELL-ASSOCIATED GPI-SPECIFIC PHOSPHOLIPASE-D
Authors: METZ CN BRUNNER G CHOIMUIRA NH NGUYEN H GABRILOVE J CARAS IW ALTSZULER N RIFKIN DB WILSON EL DAVITZ MA
Citation: Cn. Metz et al., RELEASE OF GPI-ANCHORED MEMBRANE-PROTEINS BY A CELL-ASSOCIATED GPI-SPECIFIC PHOSPHOLIPASE-D, EMBO journal, 13(7), 1994, pp. 1741-1751
COMPARISON OF 4 CATEGORIZED RISK SCORING SYSTEMS FOR ANALYZING OUTCOME IN GCSF-TREATED AND OBSERVED PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROME (MDS)
Authors: GREENBERG P TAYLOR K LARSON R KOEFFLER P NEGRIN R SABA H GANSER A JACUBOWSKI A GABRILOVE J MUFTI G CRUZ J LANGLEY G VARDIMAN J BROWN S BLAIR C LEBEAU M
Citation: P. Greenberg et al., COMPARISON OF 4 CATEGORIZED RISK SCORING SYSTEMS FOR ANALYZING OUTCOME IN GCSF-TREATED AND OBSERVED PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROME (MDS), Blood, 84(10), 1994, pp. 10000025-10000025
THE INFLUENCE OF EXTENSIVE PRIOR CHEMOTHERAPY ON THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) USING STEM-CELL FACTOR (RHSCF) AND FILGRASTIM (RMETHUG-SCF) AND ON HEMATOLOGIC RECOVERY POST CYCLOPHOSPHAMIDE, BCNU, AND VP-16 (CBV) IN PATIENTS (PTS) WITH RELAPSED NON-HODGKINS-LYMPHOMA (NHL) - AN INTERIM ANALYSIS
Authors: MOSKOWITZ C STIFF P GORDON M GABRILOVE J BAYER R BROUN R NICHOLS C HO AD WYRES M NIMER S MCNIECE I
Citation: C. Moskowitz et al., THE INFLUENCE OF EXTENSIVE PRIOR CHEMOTHERAPY ON THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) USING STEM-CELL FACTOR (RHSCF) AND FILGRASTIM (RMETHUG-SCF) AND ON HEMATOLOGIC RECOVERY POST CYCLOPHOSPHAMIDE, BCNU, AND VP-16 (CBV) IN PATIENTS (PTS) WITH RELAPSED NON-HODGKINS-LYMPHOMA (NHL) - AN INTERIM ANALYSIS, Blood, 84(10), 1994, pp. 10000107-10000107
ELEVATED INTRACELLULAR LEVELS OF BASIC FIBROBLAST GROWTH-FACTOR CORRELATE WITH STAGE OF CHRONIC LYMPHOCYTIC-LEUKEMIA AND CONFER RESISTANCE TO FLUDARABINE
Authors: MENZEL T RAHMAN Z WHITE K WIEDER R GABRILOVE J
Citation: T. Menzel et al., ELEVATED INTRACELLULAR LEVELS OF BASIC FIBROBLAST GROWTH-FACTOR CORRELATE WITH STAGE OF CHRONIC LYMPHOCYTIC-LEUKEMIA AND CONFER RESISTANCE TO FLUDARABINE, Blood, 84(10), 1994, pp. 10000525-10000525
THE INFLUENCE OF PRIOR CHEMOTHERAPY ON THE ABILITY OF PERIPHERAL-BLOOD DERIVED CD34-CELL FACTOR (SCF)PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)TO GENERATE PROGENITORS EX-VIVO( CELLS MOBILIZED BY STEM)
Authors: SHAPIRO F MOSKOWITZ C REICH L MCNIECE I HEIMFELD S NIMER S GABRILOVE J MOORE MAS
Citation: F. Shapiro et al., THE INFLUENCE OF PRIOR CHEMOTHERAPY ON THE ABILITY OF PERIPHERAL-BLOOD DERIVED CD34-CELL FACTOR (SCF)PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)TO GENERATE PROGENITORS EX-VIVO( CELLS MOBILIZED BY STEM), Blood, 84(10), 1994, pp. 10000586-10000586
AN ENDOGENOUS GLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE-D RELEASES BASIC FIBROBLAST GROWTH FACTOR-HEPARAN SULFATE PROTEOGLYCAN COMPLEXES FROM HUMAN BONE-MARROW CULTURES
Authors: BRUNNER G METZ CN NGUYEN H GABRILOVE J PATEL SR DAVITZ MA RIFKIN DB WILSON EL
Citation: G. Brunner et al., AN ENDOGENOUS GLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE-D RELEASES BASIC FIBROBLAST GROWTH FACTOR-HEPARAN SULFATE PROTEOGLYCAN COMPLEXES FROM HUMAN BONE-MARROW CULTURES, Blood, 83(8), 1994, pp. 2115-2125
INTERLEUKIN-1 - BIOLOGICAL EFFECTS IN HUMAN HEMATOPOIESIS
Authors: CROWN J JAKUBOWSKI A GABRILOVE J
Citation: J. Crown et al., INTERLEUKIN-1 - BIOLOGICAL EFFECTS IN HUMAN HEMATOPOIESIS, Leukemia & lymphoma, 9(6), 1993, pp. 433-440
Risultati: 1-25 | 26-32